XOMA Royalty Quote - XOMAO

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

25.62

Bid

25.55

Ask

25.74

Volume

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Market Cap

301.873M

Previous Close

25.62

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

11,782,723

Dividend Yield

8.17%

PE Ratio

-7.36

Earnings Per Share (EPS)

-3.47

Revenue

4.76M

Net Profit

-40.83M

XOMA Corp is a biotechnology royalty aggregator playing a unique role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnolo... XOMA Corp is a biotechnology royalty aggregator playing a unique role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.xoma.com

Headquarters

Wilmington, Delaware, USA

Founded

XOMA Royalty Corporation is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker XOMAO. The last closing price for XOMA Royalty was US$25.62. Over the last year, XOMA Royalty shares have traded in a share price range of US$ 0.00 to US$ 0.00.

XOMA Royalty currently has 11,782,723 shares outstanding. The market capitalization of XOMA Royalty is US$301.87 million. XOMA Royalty has a price to earnings ratio (PE ratio) of -7.36.

XOMA Royalty Declares Quarterly Preferred Stock Dividends

EMERYVILLE, Calif., Dec. 19, 2024 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (Nasdaq: XOMA) today announced its Board of Directors has authorized the following cash dividends to holders of...

XOMA Royalty Acquires Pulmokine for $20 Million Adding the Royalty and Milestone Interest in Seralutinib, a Phase 3 Asset, to Its Portfolio

Seralutinib becomes XOMA Royalty’s seventh Phase 3 royalty asset, further building the late-stage pipeline beyond its six current commercial royalty assets Seralutinib is being developed and...

XOMA Royalty Reports Third Quarter 2024 Financial Results and Highlights Recent Activities

Zevra’s MIPLYFFA™ (arimoclomol) received FDA approval and became the sixth commercial asset in XOMA Royalty’s portfolio XOMA Royalty acquired a 50 percent economic interest in TWIST Bioscience’s...

XOMA Royalty Significantly Expands its Royalty and Milestone Portfolio with the Addition of Over 60 Early-Stage Programs from Twist Bioscience

XOMA Royalty has acquired 50 percent of Twist’s existing royalty and milestone economics for $15 million XOMA Royalty’s portfolio now holds over 100 assets ranging from revenue-generating...

Zevra’s MIPLYFFA™ (arimoclomol) Receives Approval from U.S. Food and Drug Administration for Use in Patients with Niemann-Pick Disease Type C (NPC)

MIPLYFFA™ is the first therapy approved for use in patients with NPC, a rare genetic disorder XOMA Royalty is entitled to receive a mid-single digit royalty on MIPLYFFA™ sales and up to $52.6...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	PR
4	0	0	0	0	0	0	0	PR
12	0	0	0	0	0	0	0	PR
26	0	0	0	0	0	0	0	PR
52	0	0	0	0	0	0	0	PR
156	0	0	0	0	0	0	0	PR
260	0	0	0	0	0	0	0	PR

XOMAO - Frequently Asked Questions (FAQ)

What is the current XOMA Royalty share price?

The current share price of XOMA Royalty is US$ 25.62

How many XOMA Royalty shares are in issue?

XOMA Royalty has 11,782,723 shares in issue

What is the market cap of XOMA Royalty?

The market capitalisation of XOMA Royalty is USD 301.87M

What is the 1 year trading range for XOMA Royalty share price?

XOMA Royalty has traded in the range of US$ 0.00 to US$ 0.00 during the past year

What is the PE ratio of XOMA Royalty?

The price to earnings ratio of XOMA Royalty is -7.36

What is the cash to sales ratio of XOMA Royalty?

The cash to sales ratio of XOMA Royalty is 63.15

What is the reporting currency for XOMA Royalty?

XOMA Royalty reports financial results in USD

What is the latest annual turnover for XOMA Royalty?

The latest annual turnover of XOMA Royalty is USD 4.76M

What is the latest annual profit for XOMA Royalty?

The latest annual profit of XOMA Royalty is USD -40.83M

What is the registered address of XOMA Royalty?

The registered address for XOMA Royalty is CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801

What is the XOMA Royalty website address?

The website address for XOMA Royalty is www.xoma.com

Which industry sector does XOMA Royalty operate in?

XOMA Royalty operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
APMAptorum Group Ltd	US$ 5.08 (274.91%)	56.41M
ONCOOnconetix Inc	US$ 1.40 (220.37%)	117.37M
BDMDBaird Medical Investment Holdings Ltd	US$ 3.2197 (206.64%)	3.71M
VRMEVerifyMe Inc	US$ 2.0008 (153.30%)	64.96M
SVMHSRIVARU Holding Ltd	US$ 0.0628 (88.02%)	211.15M
SGMOSangamo Therapeutics Inc	US$ 1.1879 (-49.24%)	10.64M
WATTEnergous Corporation	US$ 1.535 (-42.08%)	13.96M
COCPCocrystal Pharma Inc	US$ 1.92 (-40.92%)	216.65k
ARTWArts Way Manufacturing Co Inc	US$ 2.25 (-37.50%)	617.13k
GTIGraphjet Technology	US$ 0.9373 (-28.99%)	5.5M
EYENEyenovia Inc	US$ 0.1782 (57.28%)	225.54M
SVMHSRIVARU Holding Ltd	US$ 0.0628 (88.02%)	211.15M
CRKNCrown Electrokinetics Corporation	US$ 0.1961 (41.38%)	202.39M
XTIAXTI Aerospace Inc	US$ 0.0426 (7.85%)	154.33M
BHATBlue Hat Interactive Entertainment Technology	US$ 0.1961 (58.66%)	134.97M